Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Cheryl Meguid

Concepts (87)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pancreatic Neoplasms
13
2024
918
1.200
Why?
Carcinoma, Pancreatic Ductal
5
2024
291
0.720
Why?
Neuroendocrine Tumors
2
2017
112
0.550
Why?
Digestive System Neoplasms
1
2016
9
0.490
Why?
Patient Care Planning
1
2016
169
0.440
Why?
Neoadjuvant Therapy
7
2024
462
0.440
Why?
Pancreatectomy
3
2024
285
0.390
Why?
Pancreaticoduodenectomy
3
2019
135
0.370
Why?
Patient Care Team
1
2016
686
0.320
Why?
Laparoscopy
3
2019
475
0.290
Why?
Adenoma
2
2020
218
0.250
Why?
Radiosurgery
2
2020
400
0.230
Why?
Adenocarcinoma
3
2018
927
0.220
Why?
Metastasectomy
1
2023
19
0.200
Why?
Colonic Neoplasms
1
2024
259
0.180
Why?
Nomograms
1
2022
59
0.170
Why?
ADAM10 Protein
1
2021
29
0.170
Why?
Gamma Rays
1
2021
56
0.160
Why?
Amyloid Precursor Protein Secretases
1
2021
77
0.160
Why?
Body Composition
1
2024
704
0.160
Why?
Cystadenoma, Serous
1
2020
18
0.160
Why?
Survival Rate
5
2024
2088
0.160
Why?
Radiation Injuries
1
2021
151
0.150
Why?
Cystadenocarcinoma, Serous
1
2020
84
0.150
Why?
Epithelial-Mesenchymal Transition
1
2021
219
0.140
Why?
Fibrosis
1
2021
547
0.140
Why?
Referral and Consultation
1
2024
847
0.130
Why?
Common Bile Duct Neoplasms
1
2017
27
0.130
Why?
Patient Acceptance of Health Care
1
2024
878
0.130
Why?
Ampulla of Vater
1
2017
39
0.130
Why?
Patient Compliance
1
2021
585
0.130
Why?
Radiotherapy, Intensity-Modulated
1
2018
141
0.130
Why?
Neoplasm Staging
2
2022
1461
0.120
Why?
Incidental Findings
1
2016
80
0.120
Why?
Prognosis
5
2024
4278
0.120
Why?
Retrospective Studies
10
2024
17009
0.110
Why?
Endoscopy, Digestive System
1
2016
140
0.110
Why?
Aged
9
2024
25850
0.110
Why?
Leucovorin
1
2014
101
0.110
Why?
Vitamin B Complex
1
2014
40
0.110
Why?
Membrane Proteins
1
2021
1165
0.110
Why?
Radiography
1
2016
842
0.100
Why?
Clinical Decision-Making
1
2016
358
0.090
Why?
Middle Aged
9
2024
35762
0.090
Why?
Breast Neoplasms
1
2024
2447
0.080
Why?
Follow-Up Studies
4
2024
5389
0.080
Why?
Antineoplastic Agents
1
2021
2192
0.080
Why?
Lung Neoplasms
1
2023
2637
0.080
Why?
Humans
15
2024
144261
0.070
Why?
Quality of Life
1
2019
3166
0.060
Why?
Postoperative Complications
1
2019
2916
0.060
Why?
Female
10
2024
77976
0.060
Why?
Aged, 80 and over
3
2024
8243
0.050
Why?
Male
9
2024
72035
0.050
Why?
Age Factors
2
2022
3313
0.050
Why?
Anthropometry
1
2024
199
0.050
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2024
1953
0.050
Why?
CA-19-9 Antigen
1
2022
31
0.040
Why?
Disease-Free Survival
1
2023
768
0.040
Why?
Ephrin-B2
1
2021
45
0.040
Why?
Tumor Burden
1
2022
319
0.040
Why?
Chemoradiotherapy
1
2022
237
0.040
Why?
Adult
5
2024
40262
0.040
Why?
Adipose Tissue
1
2024
651
0.040
Why?
Tumor Cells, Cultured
1
2021
919
0.040
Why?
Treatment Outcome
3
2021
11643
0.040
Why?
Proportional Hazards Models
1
2022
1322
0.030
Why?
Xenograft Model Antitumor Assays
1
2021
928
0.030
Why?
Operative Time
1
2017
175
0.030
Why?
Comorbidity
1
2022
1646
0.030
Why?
Neoplasm Recurrence, Local
1
2023
1137
0.030
Why?
Cell Movement
1
2021
965
0.030
Why?
Prospective Studies
2
2019
7970
0.030
Why?
Sex Factors
1
2022
2096
0.030
Why?
Perioperative Care
1
2018
230
0.030
Why?
Combined Modality Therapy
1
2018
1264
0.030
Why?
Survival Analysis
1
2017
1382
0.030
Why?
Cell Proliferation
1
2021
2494
0.020
Why?
Young Adult
2
2022
13990
0.020
Why?
Apoptosis
1
2021
2430
0.020
Why?
Length of Stay
1
2016
1335
0.020
Why?
Lung
1
2023
4108
0.020
Why?
Adolescent
2
2022
22281
0.020
Why?
Mice, Inbred C57BL
1
2021
5988
0.020
Why?
United States
1
2021
15876
0.010
Why?
Mice
1
2021
18329
0.010
Why?
Animals
1
2021
38030
0.010
Why?
Meguid's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)